Fig. 1

Effects of BL21 and LRa05 on glucose homeostasis in T2DM mice. Schematic diagram of test flow (A), fasting blood glucose level during the test (B), and area under the curve of oral glucose tolerance test at week 12 (C) in T2DM mice. Data are presented as mean and standard deviation (SD) in B and C. CTL: control; T2DM: type 2 diabetes mellitus; PRO: BL21 and LRa05 mixture (109 CFU each). *p < 0.05, **p < 0.01 and ***p < 0.001 vs T2DM group